# Antibiofilm activity of three-dimensional bacterial nanocellulose scaffolds containing antimicrobial agents

**Authors:** Fernanda Keil Kressin, Isabela Aparecida Stahelin, Gilmar da Rosa Souza, Karina Cesca, Ricardo Ruiz Mazzon, Rayssa Sabino-Silva, Taynara Santos Goulart, Cleonice da Silveira Teixeira, Lucas da Fonseca Roberti Garcia, Josiane de Almeida

PMC · DOI: 10.1590/0103-644020256820 · Brazilian Dental Journal · 2026-01-30

## TL;DR

This study tested 3D nanocellulose scaffolds with antimicrobial agents to see how well they fight bacterial biofilms in a lab setting.

## Contribution

The novelty is evaluating the antibiofilm activity of BNC scaffolds with specific antimicrobial agents in a multispecies biofilm model.

## Key findings

- BNC scaffolds with amoxicillin showed significantly lower CFU values in the first 24 hours.
- SEM and CLSM showed fewer microorganisms on antimicrobial BNC scaffolds initially.
- Antimicrobial activity was most effective in the early stages of incubation.

## Abstract

Studies have focused on the use of alternative scaffolds for Regenerative Endodontic Procedures (REPs) because current materials still pose significant technical limitations. The purpose of this in vitro study was to evaluate the antibiofilm activity of three-dimensional bacterial nanocellulose (BNC) scaffolds incorporated with 0.12% chlorhexidine digluconate (BNC/CHX), 1% amoxicillin (BNC/AMOX), and 1% clindamycin (BNC/CLI). BNC scaffolds without an antimicrobial agent composed the control group (BNC/C). BNC scaffolds were immersed in a multispecies culture of E. faecalis, A. naeslundii, and S. sanguinis, which served as a substrate for biofilm growth. After 24 hours, 7, and 15 days, the mean value of colony-forming units (CFUs) was determined. Multispecies biofilm formation on the BNC scaffolds was assessed under Scanning Electron Microscopy (SEM) and Confocal Laser Scanning Microscopy (CLSM). For the biofilm cell viability test, the mean value of CFU/mL for each sample was determined, and the data were normalized by taking the base-10 logarithm (log10) of each CFU/mL value. Data were analyzed by Two-way ANOVA, followed by Bonferroni’s post-hoc multiple comparisons (α=5%). In the 24h period, BNC/AMOX demonstrated significantly lower CFUs mean values than BNC/CHX, BNC/CLI, and BNC/C (p<0.05). CFUs mean values increased throughout the experimental periods, with no significant difference compared to the other groups (p>0.05). SEM and CLSM analysis revealed, in the initial periods, a lower number of microorganisms in the experimental groups compared to the control group. BNC scaffolds containing 1% amoxicillin and 1% clindamycin demonstrated greater antimicrobial activity against a multispecies biofilm within the initial periods of incubation

## Linked entities

- **Chemicals:** chlorhexidine digluconate (PubChem CID 29089), amoxicillin (PubChem CID 33613), clindamycin (PubChem CID 446598)

## Full-text entities

- **Chemicals:** C (MESH:D002244), chlorhexidine digluconate (MESH:C010882), AMOX (MESH:D000658), clindamycin (MESH:D002981), CHX (-)
- **Species:** Streptococcus sanguinis (species) [taxon 1305], Actinomyces naeslundii (species) [taxon 1655], Enterococcus faecalis (species) [taxon 1351]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12858199/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12858199/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12858199/full.md

---
Source: https://tomesphere.com/paper/PMC12858199